HNF4α srRNA(Shanghai Changzheng Hospital)

N/A

Report date: 2025/04/23 20:01:04
NME

Base Information

Drug NameHNF4α srRNA(Shanghai Changzheng Hospital)
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionHepatocyte nuclear factor 4 modulators
TargetsHepatocyte nuclear factor 4
Therapy Area/IndicationsRectal NeoplasmsCholangiocarcinoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesShanghai Changzheng Hospital
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Changzheng Hospital
Inactive CompaniesN/A
Active IndicationsRectal NeoplasmsCholangiocarcinoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A